Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Código QR

Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Background: For most patients with acute myeloid leukemia (AML) harboring a trisomy 8 an allogeneic hematopoietic stem cell transplantation (HSCT) is a suitable and recommended consolidation therapy. However, comparative outcome analyses between patients with and without trisomy 8 undergoing allogen...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Donata Backhaus, Madlen Jentzsch, Lara Bischof, Dominic Brauer, Christina Wilhelm, Julia Schulz, Georg-Nikolaus Franke, Wolfram Pönisch, Vladan Vucinic, Uwe Platzbecker, Sebastian Schwind
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	trisomy 8 AML allogeneic HSCT MRD Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/797cdbdae53349c79acd6c63e269a2f6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Minimal Residual Disease Prior to and After Haematopoietic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia: What Level of Negativity Is Relevant?
por: Pietro Merli, et al.
Publicado: (2021)

Effect of Amnion-Wrapped Allogenic Nerve Bridging on Peripheral Nerve Injury
por: Zhang,Yan-Ru, et al.
Publicado: (2013)

Altered calcium currents in cultured sensory neurons of normal and trisomy 16 mouse fetuses, an animal model for human trisomy 21 (Down Syndrome)
por: CAVIEDES,PABLO, et al.
Publicado: (2006)

Conventional Cytogenetic and Molecular Analysis in Acute Myeloid Leukemia (AML) and Their Association with Overall Survival
por: Shakeri S., et al.
Publicado: (2021)

Femtosecond Laser-assisted Allogenic Additive Stromal Keratoplasty With or Without Excimer Laser Donor Keratomileusis for Management of Keratoconus
por: Mohammad-Reza Jafarinasab, et al.
Publicado: (2021)

CORRELATION OF TRISOMY 12 WITH CLINICAL FEATURES AND OTHER LABORTARY PARAMETERS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA
por: Ali Ahmed, et al.
Publicado: (2021)

Small-molecule aggregation inhibitors reduce excess amyloid in a trisomy 16 mouse cortical cell line
por: LIMA,ANDRÉA C PAULA, et al.
Publicado: (2008)

Additional Evidence for Neuropsychiatric Manifestations in Mosaic Trisomy 20: A Case Report and Brief Review
por: Marco Colizzi, et al.
Publicado: (2021)

Immune response to allogeneic equine mesenchymal stromal cells
por: J. Lacy Kamm, et al.
Publicado: (2021)

Mathematical Modeling of Within-Host, Untreated, Cytomegalovirus Infection Dynamics after Allogeneic Transplantation
por: Elizabeth R. Duke, et al.
Publicado: (2021)

CD4+ T cells in aged or thymectomized recipients of allogeneic stem cell transplantations
por: Takahashi,Hiroshi, et al.
Publicado: (2015)

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
por: Yan-Ruide Li, et al.
Publicado: (2021)

Frecuencia de los genes de fusión TEL/AML1 y BCR/ABL en pacientes pediátricos con leucemia linfoblástica aguda
por: Artigas A,Carmen Gloria, et al.
Publicado: (2006)

CONCENTRATIONS OF IgG SUBCLASSES IN ALLOGENEIC BONE MARROW RECIPIENTS
por: A. V. Klimovich, et al.
Publicado: (2014)

Donor‐derived M2 macrophages attenuate GVHD after allogeneic hematopoietic stem cell transplantation
por: Ryo Hanaki, et al.
Publicado: (2021)

The Latest Developments in Immunomodulation of Mesenchymal Stem Cells in the Treatment of Intrauterine Adhesions, Both Allogeneic and Autologous
por: Jia-ming Chen, et al.
Publicado: (2021)

From Hematopoietic Stem Cell Transplantation to Chimeric Antigen Receptor Therapy: Advances, Limitations and Future Perspectives
por: Elisaveta Voynova, et al.
Publicado: (2021)

Bone Marrow-Resident Vδ1 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and Myeloma
por: Franziska Brauneck, et al.
Publicado: (2021)

Recomendaciones de cuidados en salud de personas con síndrome de Down: 0 a 18 años
por: Lizama C,Macarena, et al.
Publicado: (2013)

Application of Second-Generation Swept-Source Anterior Segment-OCT in the Measurement of Marginal Reflex Distance-1 (MRD-1)
por: Ogasawara K
Publicado: (2020)

CSF1R Inhibition Combined with GM-CSF Reprograms Macrophages and Disrupts Protumoral Interplays with AML Cells
por: Tatiana Smirnova, et al.
Publicado: (2021)

Prenatal diagnosis of mosaic trisomy 16 by amniocentesis in a pregnancy associated with abnormal first-trimester screening result (low PAPP-A and low PlGF), intrauterine growth restriction and a favorable outcome
por: Chih-Ping Chen, et al.
Publicado: (2021)

Risk factors for late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: analysis of 227 cases
por: XIONG Yiying, et al.
Publicado: (2021)

Recommendations on service delivery to help reduce suffering and anxiety in patients and caregivers post-hematopoietic cell transplantation: a case report
por: Jaleel Mohammed, et al.
Publicado: (2021)

Hematopoietic stem cell transplantation: clinical use and perspectives
por: Barriga,Francisco, et al.
Publicado: (2012)

The Use of Voriconazole as Primary Prophylaxis for Invasive Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation: A Single Center’s Experience
por: Ali Atoui, et al.
Publicado: (2021)

Risk, Characteristics and Biomarkers of Cytokine Release Syndrome in Patients with Relapsed/Refractory AML or MDS Treated with CD3xCD123 Bispecific Antibody APVO436
por: Fatih M. Uckun, et al.
Publicado: (2021)

Outcome After Azacitidine Treatment in Patients with High-Risk Myeolodysplastic Syndrome, Chronic Myelomonocytic Leukemia Type 2 and Acute Myeloid Leukemia – A Single Center Experience (Preliminary Data)
por: Varbanova V., et al.
Publicado: (2020)

Efficacy and safety of posaconazole in prevention of invasive fungal infections during allogeneic hematopoietic stem cell transplantation: a single-center retrospective analysis
por: ZHANG Yanfang, et al.
Publicado: (2021)

Prevalencia al nacimiento de aberraciones cromosómicas en el Hospital Clínico de la Universidad de Chile: Período 1990-2001
por: Nazer H,Julio, et al.
Publicado: (2003)

Sarcoma mieloide: Caso clínico con trisomia 11
por: Lincopán S,Anya, et al.
Publicado: (2011)

Charlson comorbidity index predicts outcomes of elderly after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome
por: Sheng-Hsuan Chien, et al.
Publicado: (2021)

Impact of obinutuzumab alone and in combination for follicular lymphoma
por: Sarraf Yazdy M, et al.
Publicado: (2017)

Transfer of Cellular Content from the Allogeneic Cell-Based Cancer Vaccine DCP-001 to Host Dendritic Cells Hinges on Phosphatidylserine and Is Enhanced by CD47 Blockade
por: Haoxiao Zuo, et al.
Publicado: (2021)

Dynamic imaging of allogeneic adipose-derived regenerative cells transplanted in ischemic hind limb of apolipoprotein E mouse model
por: Zheng Y, et al.
Publicado: (2016)

Profile of sapacitabine: potential for the treatment of newly diagnosed acute myeloid leukemia in elderly patients
por: Lim MY, et al.
Publicado: (2014)

An insight into the utilization of allogenic blood transfusion and factors affecting blood transfusion in total knee replacement surgery in a tertiary care hospital in Eastern India
por: Sudipta Sekhar Das, et al.
Publicado: (2021)

Adalimumab Therapy in a Patient with Psoriasis, Down Syndrome, and Concomitant Hepatitis B Virus Infection
por: Madani A, et al.
Publicado: (2021)

Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in the contemporary era
por: Sanghee Hong, et al.
Publicado: (2021)

mSphere of Influence: Considering Complex Mutational Processes That Shape Microbial Virulence
por: Matthew Zack Anderson
Publicado: (2019)